AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

Sales and UpgradesContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

14 Jun
AHFS Drug Information logo
AHFS June 2022 Update

This update contains 15 revised monographs.

Revised monographs: Aducanumab; Apomorphine; Afatinib; Axitinib; Baricitinib; Bromocriptine; Fingolimod; Golimumab; Guselkumab; Pemigatinib; Ponesimod; Regorafenib; Ribociclib; Risankizumab-rzaa; Tofacitinib.

10 May
AHFS Drug Information logo
AHFS May 2022 Update

This update contains 2 new monographs and 25 revised monographs.

New monographs: Nivolumab and Relatlimab-rmbw; Pacritinib

Revised monographs: Acalabrutinib; Adalimumab; Brigatinib; Brodalumab; Certolizumab; COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Eptinezumab-jjmr; Erenumab-aooe; Fremanezumab-vfrm; Glatiramer; Imatinib; Infigratinib; Lanadelumab; Lurbinectedin; Nilotinib; Nitroglycerin; PAZOPanib; Pramipexole; Rimegepant; Sotrovimab; Teduglutide; Tivozanib; Trihexyphenidyl; Upadacitinib

08 Apr
AHFS Drug Information logo
AHFS April 2022 Update

This update contains 3 new monographs and 61 revised monographs.

New monographs: Abrocitinib; Bebtelovimab; Faricimab

Revised monographs: Alprostadil; Alteplase; Amantadine; Amiodarone; Apremilast; Argatroban; Asparaginase (Erwinia chrysanthemi) (recombinant)-rywn; Avatrombopag; Belzutifan; Benztropine; Bumetanide; Cisatracurium; Dasatinib; Dexmedetomidine; dilTIAZem; Diroximel Fumarate; DOBUTamine; Dopamine; Dostarlimab-gxly; Eltrombopag; Epinephrine; Esmolol; Etanercept; fentaNYL; Furosemide; Heparin; HYDROmorphone; Ibrutinib; Insulin Human; Isoproterenol; Ketamine; Labetalol; LORazepam; Midazolam; Milrinone; Morphine; Naloxone; niCARdipine; Norepinephrine; Octreotide; Osimertinib; Pantoprazole; PENTobarbital; Phenylephrine; Pralsetinib; Propofol; Remifentanil; Ripretinib; Rocuronium; Sodium Bicarbonate; Sodium Chloride; Sodium Nitroprusside; Sonidegib; Temozolomide; Tepotinib; Terbutaline; Tranexamic Acid; Umbralisib; Vasopressin; Vecuronium; Venetoclax

08 Mar
AHFS Drug Information logo
AHFS March 2022 Update

This update contains 4 new monographs, 48 revised monographs, 12 discontinued monographs and 2 new MedWatch alerts.

New monographs: Inclisiran; Levoketoconazole; Ropeginterferon Alfa-2b; Tralokinumab

Revised monographs: Aflibercept; Aminopenicillins General Statement; Amoxicillin; Amoxicillin/Clavulanate; Ampicillin; Ampicillin/Sulbactam; Antihistamines General Statement; Argatroban; Avacopan; Bamlanivimab and Etesevimab; Berotralstat; Bevacizumab; Brolucizumab; Buprenorphine; C1-Esterase Inhibitor (Human); C1-Esterase Inhibitor (Recombinant); Casirivimab and Imdevimab; Clarithromycin; COVID-19 Vaccine (Janssen); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Diroximel Fumarate; Ecallantide; Eculizumab; Icatibant; Ixazomib Citrate; Lanadelumab-flyo; Ledipasvir and Sofosbuvir; Lemborexant; Lenalidomide; Monomethyl Fumarate; Pegcetacoplan; Pomalidomide; Preface to Penicillins; Ranibizumab; Ravulizumab-cwvz; Remdesivir; Risankizumab-rzaa; Sofosbuvir; Sofosbuvir, Velpatasvir, and Voxilaprevir; Sotorasib; Suvorexant; Thalidomide; Thiazides General Statement; Tildrakizumab-asmn; Umbralisib; Varicella Virus Vaccine Live

Discontinued monographs: Ammonium Chloride; Bendroflumethiazide; Biperiden; chlorpropamide; Diphenido; Edrophonium; Indinavir; Lesinurad; Pegaptanib; Procyclidine; raNITIdine; Tromethamine

New MedWatch alerts on the following monographs: Buprenorphine; Umbralisib

08 Feb
AHFS Drug Information logo
AHFS February 2022 Update

This update contains 7 new monographs and 43 revised monographs.

New monographs: Efgartigimod Alfa-Fcab; Maribavir; Molnupiravir; Nirmatrelvir And Ritonavir; Tezepelumab; Tixagevimab And Cilgavimab; Vosoritide.

Revised monographs: Atorvastatin; Bamlanivimab and Etesevimab; Bivalirudin; Cangrelor; Casirivimab and Imdevimab; Clopidogrel; Cobimetinib; COVID-19 Vaccine (Janssen); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Dexmethylphenidate/Serdexmethylphenidate; Diclofenac; Dimethyl Fumarate; Diroximel Fumarate; Entrectinib; Factor Xa (recombinant), Inactivated-zhzo; Fedratinib; Fluvastatin; Glasdegib; HMG-CoA Reductase Inhibitors General Statement; Hyperosmotic Laxatives; idaruCIZUmab; Iloperidone; Imipenem and Cilastatin; Ivosidenib; Lenvatinib; Loncastuximab; Lovastatin; Meningococcal Groups A, C, Y, and W-135 Vaccine; Methylphenidate; Monomethyl Fumarate; Palbociclib; Pitavastatin; Pravastatin; Prothrombin Complex Concentrate; Remdesivir; Rosuvastatin; Selpercatinib; Simvastatin; Sotrovimab; Sucroferric Oxyhydroxide; Sugammadex; Ursodiol

11 Jan
AHFS Drug Information logo
AHFS Drug Information January 2022 Update

This update contains 2 new monographs and 43 revised monographs.

New monographs: Asciminib; Tick-borne Encephalitis Vaccine

Revised monographs: Linezolid; Fondaparinux; Flurbiprofen; Bedaquiline; Olaparib; Obeticholic Acid; Rucaparib; Niraparib; Pretomanid; Lefamulin; Tazemetostat; Cefiderocol; Capmatinib; Ofatumumab; COVID-19 Vaccine (Pfizer-BioNTech); Relugolix; Fenoprofen; Indomethacin; Mefenamic Acid; Tolmetin; Sulindac; Prochlorperazine; Trifluoperazine; Perphenazine; fluPHENAZine; Neostigmine; Molindone; Meclofenamate; Loxapine; Chloroquine; Hydroxychloroquine; Thiothixene; Aspirin; Salsalate; Phenothiazines General Statement; Diflunisal; Piroxicam; Ketoprofen; Pimozide; cloZAPine; Etodolac; Nabumetone; Oxaprozin

View more View all content updates